China Universal Asset Management Co., Ltd.

Position in ACIU — AC Immune SA

CIK 1906594 SHANGHAI, F4

Position in ACIU

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$49,093

-$2,283 QoQ

Shares Held

17,852

+9.1% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

China Universal Asset Management Co., Ltd. holds $172,298,843 across 225 Biotechnology names. ACIU ranks #196 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	43,902	$19,603,999
2	REGN	Regeneron Pharmaceuticals, Inc.	21,361	$16,504,363
3	ALNY	Alnylam Pharmaceuticals, Inc.	27,266	$9,021,501
4	INSM	INSMED Inc	47,015	$7,687,892
5	RPRX	Royalty Pharma plc	130,447	$6,257,542
6	IONS	Ionis Pharmaceuticals Inc	77,315	$5,805,583
7	ARGX	Argenx SE	5,035	$3,676,808
8	MRNA	Moderna, Inc.	70,085	$3,560,318

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$49,093	17,852	+9.1%	Shares	Sole	2026-04-28
2025-12-31	$51,376	16,362	-7.0%	Shares	Sole	2026-01-29
2025-09-30	$50,864	17,600	-12.7%	Shares	Sole	2025-11-10
2025-06-30	$40,939	20,167	+1.7%	Shares	Sole	2025-08-28
2025-03-31	$37,095	19,837	-5.4%	Shares	Sole	2025-04-30
2024-12-31	$56,619	20,970	+10.2%	Shares	Sole	2025-01-24
2024-09-30	$71,899	19,021	+63.7%	Shares	Sole	2024-10-25
2024-06-30	$46,367	11,621	-38.9%	Shares	Sole	2024-07-19
2024-03-31	$56,263	19,008	+96.5%	Shares	Sole	2024-05-21
2023-12-31	$48,370	9,674	+1135.5%	Shares	Sole	2024-05-22
2022-09-30	$2,474	783	—	Shares	Sole	2022-10-21
No filing history on record for this holder in this stock.